Published in Ann Thorac Surg on November 01, 2010
T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease. Am J Transplant (2012) 0.92
Lung transplantation: infection, inflammation, and the microbiome. Semin Immunopathol (2011) 0.86
An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection. Int J Immunogenet (2012) 0.86
The role of autoimmunity in obliterative bronchiolitis after lung transplantation. Am J Physiol Lung Cell Mol Physiol (2012) 0.83
Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection. Clin Transplant (2012) 0.82
Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications. Hum Immunol (2012) 0.78
Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr (2014) 0.78
Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation. J Am Soc Nephrol (2016) 0.76
Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation. Am J Respir Cell Mol Biol (2016) 0.76
Humoral Human Lung Allograft Rejection by Tissue-Restricted Non-HLA Antibodies. Ann Thorac Surg (2016) 0.75
Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection. J Immunol Res (2017) 0.75
Lung Injury Combined with Loss of Regulatory T Cells Leads to De Novo Lung-Restricted Autoimmunity. J Immunol (2016) 0.75
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol (2005) 13.03
Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant (1996) 3.51
IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest (2007) 3.31
Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med (2004) 1.95
De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol (2008) 1.95
CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant (2006) 1.63
Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation. Ann Thorac Surg (2006) 1.63
Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant (1998) 1.63
Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant (1996) 1.60
Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation (2007) 1.54
The role of infections in autoimmune disease. Clin Exp Immunol (2009) 1.47
The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation (2005) 1.46
A primary culture model of differentiated murine tracheal epithelium. Am J Physiol Lung Cell Mol Physiol (2000) 1.39
Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J Immunol (2003) 1.19
Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant (2004) 1.09
Immunostimulatory RNA blocks suppression by regulatory T cells. J Immunol (2009) 1.07
Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome. J Heart Lung Transplant (2009) 0.98
Immune mechanisms of lung allograft rejection. Semin Respir Crit Care Med (2006) 0.97
Animal models for bronchiolitis obliterans syndrome following human lung transplantation. Immunol Res (2005) 0.88
Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med (2008) 4.70
Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg (2006) 3.76
Video-assisted thoracoscopic lobectomy is less costly and morbid than open lobectomy: a retrospective multiinstitutional database analysis. Ann Thorac Surg (2011) 3.08
Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (2006) 2.69
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest (2006) 2.33
HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A (2008) 2.31
Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg (2002) 2.19
Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2010) 2.06
Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. J Heart Lung Transplant (2007) 2.03
Lung cancer screening. J Natl Compr Canc Netw (2012) 2.00
De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol (2008) 1.95
Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med (2004) 1.95
Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.94
Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93
Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2002) 1.86
Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg (2003) 1.80
Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol (2009) 1.74
The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg (2007) 1.65
Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol (2009) 1.64
Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation. Ann Thorac Surg (2006) 1.63
Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol (2005) 1.61
Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report--2006. J Heart Lung Transplant (2006) 1.58
Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol (2004) 1.56
Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation (2007) 1.54
Potential for detrimental hyperinflation after lung transplantation with application of negative pleural pressure to undersized lung grafts. J Thorac Cardiovasc Surg (2003) 1.54
Sternoclavicular joint infection: a comparison of two surgical approaches. Ann Thorac Surg (2011) 1.52
Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg (2005) 1.52
Benign esophageal tumors: introduction, incidence, classification, and clinical features. Semin Thorac Cardiovasc Surg (2003) 1.51
Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report--2007. J Heart Lung Transplant (2007) 1.51
A prospective evaluation of lung volume reduction surgery in 200 consecutive patients. Chest (2003) 1.51
Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg (2008) 1.50
Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg (2004) 1.50
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50
Prevalence of benign disease in patients undergoing resection for suspected lung cancer. Ann Thorac Surg (2006) 1.46
Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol (2003) 1.46
The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation (2005) 1.46
Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest (2013) 1.42
Significance of neurologic complications in the modern era of cardiac transplantation. Ann Thorac Surg (2007) 1.42
Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant (2010) 1.41
Nonoperative management of large tracheal injuries. J Thorac Cardiovasc Surg (2008) 1.40
Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high-risk criterion. J Thorac Cardiovasc Surg (2004) 1.39
Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant (2011) 1.37
The registry of the international society for heart and lung transplantation: nineteenth official report-2002. J Heart Lung Transplant (2002) 1.36
Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy. J Heart Lung Transplant (2010) 1.35
Outcomes after resection of giant emphysematous bullae. Ann Thorac Surg (2004) 1.33
Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants. Am J Respir Cell Mol Biol (2007) 1.33
Bronchial fenestration improves expiratory flow in emphysematous human lungs. Ann Thorac Surg (2003) 1.32
Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg (2010) 1.32
Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J Immunol (2006) 1.31
Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis (2005) 1.31
Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant (2005) 1.31
Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology. Nat Protoc (2009) 1.30
The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report--2003. J Heart Lung Transplant (2003) 1.29
Lymph node evaluation in video-assisted thoracoscopic lobectomy versus lobectomy by thoracotomy. Ann Thorac Surg (2010) 1.29
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg (2003) 1.28
Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant (2005) 1.27
Effects of CT section thickness and reconstruction kernel on emphysema quantification relationship to the magnitude of the CT emphysema index. Acad Radiol (2010) 1.26